ATC code A16
ATC code A16 Other alimentary tract and metabolism products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A16 is part of the anatomical group A Alimentary tract and metabolism.[4]
| ATC codes |
|---|
| A Alimentary tract and metabolism |
| A01 Stomatological preparations |
| A02 Drugs for acid related disorders |
| A03 Drugs for functional gastrointestinal disorders |
| A04 Antiemetics and antinauseants |
| A05 Bile and liver therapy |
| A06 Drugs for constipation |
| A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents |
| A08 Antiobesity preparations, excluding diet products |
| A09 Digestives, including enzymes |
| A10 Drugs used in diabetes |
| A11 Vitamins |
| A12 Mineral supplements |
| A13 Tonics |
| A14 Anabolic agents for systemic use |
| A15 Appetite stimulants |
| A16 Other alimentary tract and metabolism products |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA16.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A16A Other alimentary tract and metabolism products
A16AA Amino acids and derivatives
- A16AA01 Levocarnitine
- A16AA02 Ademetionine
- A16AA03 Levoglutamide
- A16AA04 Mercaptamine
- A16AA05 Carglumic acid
- A16AA06 Betaine
- A16AA07 Metreleptin
- QA16AA51 Levocarnitine, combinations
A16AB Enzymes
- A16AB01 Alglucerase
- A16AB02 Imiglucerase
- A16AB03 Agalsidase alfa
- A16AB04 Agalsidase beta
- A16AB05 Laronidase
- A16AB06 Sacrosidase
- A16AB07 Alglucosidase alfa
- A16AB08 Galsulfase
- A16AB09 Idursulfase
- A16AB10 Velaglucerase alfa
- A16AB11 Taliglucerase alfa
- A16AB12 Elosulfase alfa
- A16AB13 Asfotase alfa
- A16AB14 Sebelipase alfa
- A16AB15 Velmanase alfa
- A16AB16 Idursulfase beta
- A16AB17 Cerliponase alfa
- A16AB18 Vestronidase alfa
- A16AB19 Pegvaliase
- A16AB20 Pegunigalsidase alfa
- A16AB21 Atidarsagene autotemcel
- A16AB22 Avalglucosidase alfa
A16AX Various alimentary tract and metabolism products
- A16AX01 Thioctic acid
- A16AX02 Anethole trithione
- A16AX03 Sodium phenylbutyrate
- A16AX04 Nitisinone
- A16AX05 Zinc acetate
- A16AX06 Miglustat
- A16AX07 Sapropterin
- A16AX08 Teduglutide
- A16AX09 Glycerol phenylbutyrate
- A16AX10 Eliglustat
- A16AX11 Sodium benzoate
- A16AX12 Trientine
- A16AX13 Uridine triacetate
- A16AX14 Migalastat
- A16AX15 Telotristat
- A16AX16 Givosiran
- A16AX17 Triheptanoin
- A16AX18 Lumasiran
- A16AX19 Fosdenopterin
- A16AX20 Lonafarnib
- A16AX30 Sodium benzoate and sodium phenylacetate
QA16Q Other alimentary tract and metabolism products for veterinary use
QA16QA Drugs for prevention and/or treatment of acetonemia
- QA16QA01 Propylene glycol
- QA16QA02 Sodium propionate
- QA16QA03 Glycerol
- QA16QA04 Ammonium lactate
- QA16QA05 Clanobutin
- QA16QA06 Monensin
- QA16QA52 Sodium propionate, combinations
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code A16". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QA16". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.